DuPont sells Aramids business to Arclin for ~$1.8B; expects Q1 2026 close

DuPont de Nemours, Inc.

DuPont entered definitive agreement to sell Aramids (Kevlar, Nomex) to Arclin for ~$1.8B.
Consideration includes ~$1.2B pre-tax cash, $300M note, and ~17.5% equity stake valued at $325M.
Closing expected Q1 2026, subject to regulatory approvals and customary conditions.
Aramids business had 2024 net sales of $1.3B and employs ~1,900 people.
Divestiture does not affect planned spin-off of electronics business (Qnity) on track for Nov 1, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.